<DOC>
	<DOC>NCT02246166</DOC>
	<brief_summary>This phase IV multi-centre, randomised, double-blind, placebo-controlled, parallel-group, single-dose study will assess the efficacy and tolerability of the active tablets versus placebo in participants suffering from cold and influenza. Eligible participants will be randomly assigned to one of 2 treatment groups (active or placebo tablets) and enter a four-hour (hr) treatment phase. Each participant will be administered only once during each study period. Participants will use a questionnaire to record the symptom severity scores as described, as well as time.</brief_summary>
	<brief_title>The Effect of Paracetamol, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide and Chlorpheniramine Maleate Tablets Compared to Placebo in Subjects Suffering From the Common Cold or Influenza.</brief_title>
	<detailed_description />
	<mesh_term>Common Cold</mesh_term>
	<mesh_term>Pseudoephedrine</mesh_term>
	<mesh_term>Dextromethorphan</mesh_term>
	<mesh_term>Ephedrine</mesh_term>
	<mesh_term>Chlorpheniramine</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Aged at least 18 years and less than 65 years Good general and mental health in the opinion of the investigator Participants diagnosed with a common cold or flu and must have the following symptoms of at least "moderate" in intensity (≥ 2) at the screening visit (baseline), with a minimum total symptom score of 6: (i) At least one of pain symptoms: sore throat, headache, or extremities pain (ii) Mandatory: Nasal congestion (iii) At least one of catarrh symptoms: runny nose or sneezing Onset of first symptoms of cold must have occurred within 48 hours of screening. Pregnant or breast feeding women History of seasonal or perennial allergic rhinitis or acute, subchronic, or chronic cough due to any condition other than a common cold or flu, as determined by the investigator Concurrent illness or medical history that is contraindicated or cautioned about in the drug label Anatomical factors causing nasal congestion Fever with body temperature &gt;38.5°C at baseline Have used any medication or herbal remedies to treat cold prior to screening (antibiotics in the last 7 days, antihistamines in the last 72 hours, analgesics or antipyretics in the last 24 hours, decongestant in the last 12 hours, antitussive, medicated lozenge or throat spray in the last 8 hours) Any medication that has potential drugdrug interactions with study medications Known or suspected intolerance or hypersensitivity to the study materials Have a positive drug urine test or recent history (within the last 2 years) of alcohol or other substance abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>